AstraZeneca taps Scottish firm for 10th COVID-19 vaccine supply deal


AstraZeneca (AZN.L) has signed its tenth supply-and-manufacturing deal for its experimental COVID-19 vaccine with a Scotland-backed firm as the British drugmaker ramps up efforts for wider trials of the potential treatment.

Symbiosis Pharmaceutical said on Wednesday it agreed to make and supply an unspecified number of units of the vaccine, AZD1222, for AstraZeneca to use in clinical trials. The companies did not provide any financial terms of the deal.

AstraZeneca Chief Executive Officer Pascal Soriot last month warned that the company was running out of time to effectively test the vaccine as the number of cases decline in Europe.

Brazil last week became the first country outside of the UK to begin human testing of the vaccine AstraZeneca licensed from the University of Oxford. About 3,000 people in Sao Paulo and Rio de Janeiro have enrolled for trials. US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.